ask="14.98"
ask_size="200"
average_daily_volume="1829180"
bid="12.07"
bid_size="100"
book_value="-0.09"
change="-0.44"
change_from_200_day_moving_average="0.90"
change_from_50_day_moving_average="0.01"
change_from_52_week_high="-2.31"
change_From_52_week_low="4.55"
change_in_percent="-3.52%"
close="12.07"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-0.90"
ex_dividend_date="N/A"
float_shares="94803000"
high="12.46"
high_52_weeks="14.38"
last_trade_date="2/22/2017"
last_trade_price="12.07"
last_trade_size="54775"
last_trade_time="4:00pm"
low="12.07"
low_52_weeks="7.52"
market_capitalization="1.55B"
moving_average_200_day="11.17"
moving_average_50_day="12.06"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.84"
open="12.46"
pe_ratio="N/A"
peg_ratio="-0.26"
percent_change_from_200_day_moving_average="+8.10%"
percent_change_from_50_day_moving_average="+0.07%"
percent_change_from_52_week_high="-16.06%"
percent_change_from_52_week_low="+60.51%"
previous_close="12.51"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="10.03"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="8.07"
stock_exchange="NMS"
symbol="HALO"
volume="993176"
weeks_range_52="7.52 - 14.38"
